| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2024―Dez―23 |
Retrospective service evaluation of clinical pharmacist involvement in a critical care COVID-19 rehabilitation clinic |
David Sapsford, Helen Dufton, Monica Trivedi, Joanne McPeake, Andrew Conway Morris |
| 2 |
[GO] |
2024―Jun―13 |
Retrospective study of patient characteristics and treatment for mucormycosis in post COVID-19 population in a tertiary care hospital |
Jada Naga Lakshmi, Jada Bala Sai Kalyan, Tanniru Govardhana Priya, Tummala Sushma, Gaddam Rukmini, R V L S Mounica, Tinnaluri Vishnu Vardhan |
| 3 |
[GO] |
2024―Mai―15 |
An essential component of antimicrobial stewardship during the COVID-19 pandemic in the intensive care unit: de-escalation |
Aysel Pehlivanli, Cigdem Ozgun, Firdevs Gonca Sasal-Solmaz, Didem Yuksel, Bilgen Basgut, Arif Tanju Ozcelikay, Mustafa Necmettin Unal |
| 4 |
[GO] |
2024―Feb―06 |
Analysis of the use of antibiotics by AWaRe categories during the COVID-19 pandemic in hospitals across Scotland: a national population-based study |
Euan Proud, Tanja Mueller, Karen Gronkowski, Amanj Kurdi, Niketa Platt, Aidan Morrison, Marion Bennie, William Malcolm |
| 5 |
[GO] |
2023―Okt―24 |
Clinical pharmacy as a guarantee of safety in times of crisis: evolution and relevance of the continued presence of clinical pharmacists in frontline medical units during the first wave of COVID-19 |
Arnaud Tanty, Elisa Vitale, Dorothée Lombardo-Duron, Armance Grevy, Prudence Gibert, Claire Chapuis, Christine Chevallier-Brilloit, Benoît Allenet, Pierrick Bedouch, Sebastien Chanoine |
| 6 |
[GO] |
2023―Aug―17 |
COVID-19 vaccine triggered autoimmune hepatitis: case report |
Merrin Mathew, Sheba Baby John, Juny Sebastian, Mandyam Dhati Ravi |
| 7 |
[GO] |
2023―Jun―20 |
Real-world effectiveness and factors associated with increased mortality in non-critically ill patients with COVID-19 pneumonia receiving remdesivir |
Lucía Quesada Muñoz, Jorge Fernández-Fradejas, Hilario Martinez-Barros, Marina Sánchez Cuervo, Miriam Martín Rufo, Maria del Rosario Pintor Recuenco, Carmen Quereda Rodríguez-Navarro, Ana María Álvarez-Díaz, Javier Saez de la Fuente |
| 8 |
[GO] |
2023―Feb―03 |
Correspondence on ‘Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series’ |
Xiaohua Xiao Zhou, Hong Jian Ji |
| 9 |
[GO] |
2022―Dez―19 |
Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series |
Carlos Guzmán Cordero, Maria Saez-Torres de Vicente |
| 10 |
[GO] |
2022―Okt―27 |
Use of chronic medications and risk of severe death due to COVID-19 in hospitalised patients |
María Larrosa-García, Sonia Garcia-Garcia, Javier Louro, Adrián Sánchez-Montalvá, Julia Sampol Sirvent, Salvador Augustín Recio, Alfredo Guillén del Castillo, Judit Riera-Arnau, Maria Queralt Gorgas, Marta Miarons |
| 11 |
[GO] |
2022―Okt―07 |
COVID-19 vaccine triggered autoimmune hepatitis: case report |
Merrin Mathew, Sheba Baby John, Juny Sebastian, Mandyam Dhati Ravi |
| 12 |
[GO] |
2022―Okt―06 |
Monoclonal antibodies for the early treatment of paediatric COVID-19 patients: a tangible contribution from hospital pharmacists in the lack of evidence |
Sabrina Trivellato, Daniele Mengato, Daniele Donà, Marica De Pieri, Francesca Venturini |
| 13 |
[GO] |
2022―Sep―23 |
Assessment of the effectiveness of tocilizumab on mortality and progression to mechanical ventilation or intensive care in patients with COVID-19 admitted to a tertiary hospital |
Andrea Pinilla Rello, Arantxa Magallón Martínez, Cristina Vicente Iturbe, Angel Escolano-Pueyo, Elena Herranz Bayo, Irene Aguilo Lafarga |
| 14 |
[GO] |
2022―Aug―23 |
EAHP’s COVID-19 Report showcases the contributions of hospital pharmacists and shares recommendations |
Gonzalo Marzal Lopez |
| 15 |
[GO] |
2022―Apr―15 |
A qualitative evaluation of weekly reflective practice sessions for the intensive care unit pharmacy team during the COVID-19 pandemic |
Naima Fowlis, Nina Barnett, Sara Banks, Barry Jubraj |
| 16 |
[GO] |
2022―Mrz―30 |
Analysis of clinical enquiries received by five COVID-19 vaccination centres in the UK |
Sukhpreet Bassi, Rubena Begum, Raliat Onatade, Catherine Olie |
| 17 |
[GO] |
2022―Jan―06 |
Tocilizumab in COVID-19 management: addressing time of starting treatment |
Sajad Khiali, Taher Entezari-Maleki |
| 18 |
[GO] |
2021―Okt―18 |
Medicine shortages in the hospital setting: analysis of the trend in five Italian centres during the three waves of the SARS-CoV-2 pandemic |
Ludovica Mazzoleni, Andrea Zovi, Cecilia Borsino, Cinzia D'Angelo |
| 19 |
[GO] |
2021―Okt―14 |
Effectiveness of antithrombotic prophylaxis in hospitalised patients with SARS-CoV-2 infection |
Helena Quiros Ambel, Paloma Crespo-Robledo, Karmele Arribalzaga Juaristi, Isabel Plo-Seco, Jose Javier Martínez Simón, Elia Pérez Fernández, Monserrat Perez Encinas |
| 20 |
[GO] |
2021―Sep―08 |
Lessons learnt from the COVID-19 pandemic: results of EAHP survey on the future crisis preparedness of hospital pharmacies |
Daniele Leonardi Vinci, Piera Polidori, Nenad Miljković, Aida Batista, Steffen Amann, Despina Makridaki, Stephanie Kohl |
| 21 |
[GO] |
2021―Aug―23 |
Preparation of COVID-19 vaccines in hospital pharmacies: a half-year report from Slovakia |
Boris Dudík, Ľubica Slimáková, Hajnalka Komjáthy, Melisa Švecová, Andrea Bundzelová, Bianka Oboňová, Adriána Šusterová, Katarína Tóthová |
| 22 |
[GO] |
2021―Aug―16 |
Risk factors for nosocomial bloodstream infections in COVID-19 affected patients: protocol for a case-control study |
Carla Codina-Jiménez, Sergio Marin, Marlene Álvarez, Maria Dolores Quesada, Beatriz Rodríguez-Ponga, Ester Valls, Carles Quiñones |
| 23 |
[GO] |
2021―Jul―28 |
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients |
Rubén Iglesias Gómez, Raúl Méndez, Tomás Palanques-Pastor, Octavio Ballesta-López, Conxa Borrás Almenar, Juan Eduardo Megías Vericat, Eduardo López-Briz, Isabel Font-Noguera, Rosario Menéndez Villanueva, José Andrés Román Iborra, José Luis Poveda Andrés |
| 24 |
[GO] |
2021―Jul―16 |
The dynamics in applied COVID-19 pharmacotherapy and the influence of national guidance in The Netherlands: a quantitative and qualitative study |
Elien B Uitvlugt, Danny Y F Soeng, Paul van der Linden, Ewoudt M W van de Garde |
| 25 |
[GO] |
2021―Jun―03 |
Benefit versus toxicity risk of digoxin in patients with COVID-19 |
Burcu Kelleci Cakir, Aygin Bayraktar-Ekincioglu, Kutay Demirkan |
| 26 |
[GO] |
2021―Mai―19 |
Treatment of high-risk bleeding with susoctocog alfa in a patient with acquired haemophilia A and a nosocomial severe acute respiratory syndrome coronavirus 2 infection |
Carla Fernández-Oliveira, Sandra Rotea-Salvo, Marta Fernández-Docampo, Sara González-Piñeiro, Isabel Martín-Herranz |
| 27 |
[GO] |
2021―Mai―14 |
Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-19 |
Shaghayegh Mohsenian Naghani, Mark MPM Jansen, Tessa Jaspers, Diane Bastiaans, David Burger |
| 28 |
[GO] |
2021―Mai―14 |
SARS-CoV-2: an opportunity for hospital pharmacy |
Raquel Claramunt García, Carmen Lucía Muñoz-Cid, Andrés Sánchez Ruiz |
| 29 |
[GO] |
2021―Apr―23 |
The European coalition for vaccination calls on healthcare professionals to get vaccinated against COVID-19 |
Stephanie Kohl |
| 30 |
[GO] |
2021―Apr―21 |
Administration of benralizumab in a patient with severe asthma admitted to the intensive care unit with COVID-19 pneumonia: case report |
Johannes Anthon Kroes, Sander Wilhelm Zielhuis, Carina Bethlehem, Anneke Ten Brinke, Eric Nico Van Roon |
| 31 |
[GO] |
2021―Apr―14 |
Hospital pharmacy response to COVID-19 at two UK teaching hospitals: a departmental review of actions implemented to inform future strategy |
Jeff Aston, Inderjit Singh, Caroline Cheng, Aisling Considine |
| 32 |
[GO] |
2021―Apr―13 |
COVID-19 impact on skills and professional perceptions of the hospital pharmacist during the first outbreak wave |
Vera Damuzzo, Riccardo Bertin, Daniele Mengato, Marco Chiumente, Melania Rivano, Angelo Claudio Palozzo |
| 33 |
[GO] |
2021―Apr―13 |
Hand hygiene for healthcare workers: did we need COVID-19 to raise awareness of proper disinfection practice? |
Daniele Mengato, Lorenzo Di Spazio |
| 34 |
[GO] |
2021―Apr―08 |
Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19 |
Christian Skalafouris, Caroline Samer, Jerome Stirnemann, Olivier Grosgurin, François Eggimann, Damien Grauser, Jean-Luc Reny, Pascal Bonnabry, Bertrand Guignard |
| 35 |
[GO] |
2021―Mrz―31 |
Managing the risk of shortages and medication errors with curares during the COVID-19 pandemic: a hospital pharmacy experience |
Xavier Bohand, Dominique Jordan, Frederique Dubois |
| 36 |
[GO] |
2021―Mrz―11 |
Analysis of clinical pharmacist interventions in the COVID-19 units of a French university hospital |
Maxime Perez, Morgane Masse, Anne Deldicque, Jean Baptiste Beuscart, Pascal De Groote, Jacques Desbordes, Stéphanie Fry, Elodie Musy, Pascal Odou, Francois Puisieux, Marc Lambert, Arnaud Scherpereel, Bertrand Décaudin |
| 37 |
[GO] |
2021―Feb―24 |
Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19 |
Raquel Moreno Diaz, Miguel Angel Amor García, Francisco Javier Teigell Muñoz, Leonardo Ernesto Saldaña Perez, María Mateos Gonzalez, Jose Antonio Melero Bermejo, Alberto López Hernández, Laura Reyes Marquez, Maria Teresa De Guzman García-Monge, Jose Luis Perez Quero, Marcela Patricia Homez Guzman |
| 38 |
[GO] |
2021―Feb―22 |
The European COVID-19 drugs calculation tool: an aid for the estimation of the drugs needed during the SARS-CoV 2 pandemic |
Daniele Leonardi Vinci, Adriano Meccio, Alessio Provenzani, Maria Ernestina Faggiano, Nenad Miljković, Despina Makridaki, Petr Horák, Piera Polidori |
| 39 |
[GO] |
2021―Feb―19 |
EAHP opinion on COVID-19 vaccine programmes and their implementation |
Stephanie Kohl |
| 40 |
[GO] |
2021―Feb―19 |
Information on COVID-19 vaccines and vaccinations |
Stephanie Kohl |
| 41 |
[GO] |
2021―Feb―08 |
SARS-COV-2 pandemic: establishing three risk levels for 19 Italian regions and two autonomous provinces |
Andrea Messori, Manuela Angileri, Marco Chiumente, Laura Agnoletto, Paolo Baldo, Laura Bartoli, Mario Cirino, Vera Damuzzo, Elisa Ferracane, M Cecilia Giron, Carolina Laudisio, Daniele Mengato, Angelo Claudio Palozzo, Sabrina Trippoli |
| 42 |
[GO] |
2021―Feb―05 |
Haematology patients infected with SARS-CoV-2, pretreated with eculizumab or siltuximab, develop oligosymptomatic disease |
Sabina Iluta, Sergiu Pasca, Delia Dima, Gabriela Mester, Laura Urian, Anca Bojan, Mihnea Zdrenghea, Adrian Trifa, Ovidiu Balacescu, Ciprian Tomuleasa |
| 43 |
[GO] |
2021―Jan―27 |
Web searches for anxiolytic drugs during the COVID-19 outbreak in the USA |
Giuseppe Lippi, Brandon M Henry, Fabian Sanchis-Gomar |
| 44 |
[GO] |
2021―Jan―27 |
Is sitagliptin effective for the treatment of COVID-19? |
Hasan Memiş, Ahmet Çakır, Mefküre DURMUŞ, Selim GÖK, Ömer Faruk Bahçeciȯğlu |
| 45 |
[GO] |
2021―Jan―15 |
A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report |
Fátima Falcão, Erica Viegas, Ines Carmo, Joana Soares, Margarida Falcao, Mariana Solano, Patricia Cavaco, Dina Mendes, João Rijo, Pedro Povoa, Antonio Pais Martins, Eduarda Carmo, Kamal Mansinho, Candida Fonseca, Luis Campos, António Carvalho, Ana Mirco, Helena Farinha, Isabel Aldir, José Correia |
| 46 |
[GO] |
2020―Dez―22 |
Some reflections on the current COVID-19 pandemic |
Philip Wiffen |
| 47 |
[GO] |
2020―Dez―22 |
Epinephrine use in COVID-19: friend or foe? |
Pan Luo, Dong Liu, Juan Li |
| 48 |
[GO] |
2020―Dez―05 |
Investigating the challenges and opportunities for medicines management in an NHS field hospital during the COVID-19 pandemic |
Jennifer de Val, Gurjit Sohal, Asif Sarwar, Haseeb Ahmed, Inderjit Singh, Jamie J Coleman |
| 49 |
[GO] |
2020―Nov―25 |
Prescribing practices of lopinavir/ritonavir, hydroxychloroquine and azithromycin during the COVID-19 epidemic crisis and pharmaceutical interventions in a French teaching hospital |
Benedicte Gourieux, Fanny Reisz, Anne Sophie Belmas, François Danion, Marion Fourtage, Thierry Nai, Aurélie Reiter-Schatz, Yvon Ruch, Julia Walther, Yasmine Nivoix, Bruno Michel |
| 50 |
[GO] |
2020―Nov―20 |
Prescription profile in patients with SARS-CoV-2 infection hospitalised in Aragon, Spain |
Adriana Alvarez, Laura Cabia, Cristina Trigo, Ana Cristina Bandrés, María Bestué |
| 51 |
[GO] |
2020―Okt―28 |
Implementation of a novel home delivery service during pandemic |
Ana Peláez Bejarano, Pilar Villar Santos, Maria de las Aguas Robustillo-Cortés, Ernesto Sánchez Gómez, Maria Dolores Santos Rubio |
| 52 |
[GO] |
2020―Sep―10 |
Observational study on off-label use of tocilizumab in patients with severe COVID-19 |
Laetitia Albertini, Mickael Soletchnik, Anais Razurel, Johana Cohen, Frédéric Bidegain, Francis Fauvelle, Geoffroy Safrano, Jacques Piquet, Cyril Maurer, Dany Goldgran-Toledano |
| 53 |
[GO] |
2020―Jul―31 |
Consistency of recommendations from clinical practice guidelines for the management of critically ill COVID-19 patients |
Chia Siang Kow, Toby Capstick, Syed Tabish Razi Zaidi, Syed Shahzad Hasan |
| 54 |
[GO] |
2020―Jul―13 |
Informing critical care drug requirements in response to the COVID-19 pandemic |
Anita Hogg, Rachel Huey, Michael G Scott, Andrew Ferguson |
| 55 |
[GO] |
2020―Jul―03 |
Do psychotropic drugs used during COVID-19 therapy have an effect on the treatment process? |
Nadir Yalçın, Sertaç Ak, Kutay Demirkan |
| 56 |
[GO] |
2020―Jun―10 |
Fighting on two fronts: drug-drug interactions in people living with HIV infected with SARS-CoV-2 |
Melda Bahap, Emre Kara, Gulay Sain Guven |
| 57 |
[GO] |
2020―Jun―04 |
Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19 |
Tomás Palanques-Pastor, Eduardo López-Briz, José Luis Poveda Andrés |
| 58 |
[GO] |
2020―Mai―26 |
Investigation on cognition of covid-19 and safety during the pandemic among hospital pharmacy staff |
Yan He, Wei Li, Dong Liu |
| 59 |
[GO] |
2020―Apr―23 |
EAHP launches COVID-19 resource centre for hospital pharmacists |
Stephanie Kohl |
| 60 |
[GO] |
2020―Mrz―19 |
The healthcare and pharmaceutical vulnerability emerging from the new Coronavirus outbreak |
Daniele Leonardi, Carlo Polidori, Piera Polidori |
| 61 |
[GO] |
2020―Feb―21 |
Houston we have a problem: coronavirus! |
Philip Wiffen |
